Functional brain imaging of cognitive dysfunction in Parkinson's disease
Shigeki Hirano1, Hitoshi Shinotoh, David Eidelberg
1Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan. s_hirano@chiba-u.jp
Journal of Neurology, Neurosurgery, and Psychiatry
|July 19, 2012
Summary
Cognitive impairment in Parkinson's disease (PD) arises from multiple factors, including brain changes and neurotransmitter issues. Imaging studies help understand these complex causes for better treatment.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Cognitive impairment is a common and complex issue in Parkinson's disease (PD).
- Multiple pathological factors contribute to cognitive decline in PD, including dopaminergic, cholinergic, and amyloid pathologies, as well as cerebrovascular disease.
Purpose of the Study:
- To explore the multifactorial nature of cognitive impairment in Parkinson's disease.
- To review the role of various underlying pathologies and imaging techniques in understanding PD-related cognitive changes.
Main Methods:
- Review of existing literature on Parkinson's disease and cognitive impairment.
- Analysis of findings from imaging studies, including positron emission tomography (PET) with various tracers and metabolic/perfusion imaging.
Main Results:
- Dopaminergic and cholinergic dysfunctions significantly impact executive functions and dementia in PD.
- Imaging reveals associations between posterior brain activity, amyloid deposition, and metabolic changes with cognitive decline in PD patients.
- A distinct "PD related cognitive pattern" with reduced frontoparietal activity can aid in monitoring cognitive function.
Conclusions:
- Cognitive impairment in PD is not attributable to a single mechanism but is a result of intertwined pathological factors.
- Advanced imaging techniques are crucial for elucidating individual pathological domains and their interrelations.
- Integrating imaging findings offers potential for personalized therapeutic strategies in PD and other dementia-related disorders.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...